Content provided in partnership with
Health Care Industry
Industry: Email Alert RSS Feed…but will fight merck for fosamax
Drug Store News, Nov 19, 2001
Merck & Co. is suing Teva in an attempt to keep its hold on branded osteoporosis drug Fosamax until 2008. Merck asserts that its ownership of a "method for inhibiting bone reabsorption" protects Fosamax for another six years. Merck also sued Barr Labs, another generic maker, on the same grounds several months ago.
- Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »
Teva applied to the FDA for fast track status to sell its generic form of Fosamax in the United States. Early statements hint that Teva will fight Merck's charge. Annual Fosamax sales are $762.7 million, making it the No. 1 osteoporosis drug in sales and prescriptions.
COPYRIGHT 2001 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
Find Research Guides for:
Find Featured Titles for: Home & Garden
Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »